A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer
Open Access
- 16 March 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 90 (8), 1516-1520
- https://doi.org/10.1038/sj.bjc.6601736
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Gemcitabine and Cisplatin Is a Highly Effective Combination Chemotherapy in Patients With Advanced Cancer of the GallbladderAmerican Journal of Clinical Oncology, 2003
- Phase II Trial of the Use of Gemcitabine and 5-Fluorouracil in the Treatment of Advanced Pancreatic and Biliary Tract CancerAmerican Journal of Clinical Oncology, 2003
- Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.2003
- Review of gemcitabine in biliary tract carcinomaSeminars in Oncology, 2002
- Chemotherapy in biliary tract carcinomas: Results in IndiaSeminars in Oncology, 2002
- Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?Cancer, 2002
- A phase II study of gemcitabine and oxaliplatin (gemox) in advanced biliary adenocarcinoma (ABA). Preliminary resultsEuropean Journal of Cancer, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Biliary Tract CancersThe New England Journal of Medicine, 1999
- Phase II study of gemcitabine in patients with nonresectable cancer of the biliary systemEuropean Journal of Cancer, 1999